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Myeloperoxidase is abundantly present in inﬂammatory diseases where activation of monocytes/macro-
phages and T-cell-mediated immune response occurs. The potent oxidant hypochlorous acid (HOCl), gen-
erated by the myeloperoxidase–H2O2–chloride system of activated phagocytes, converts low-density
lipoprotein (LDL) into a proinﬂammatory lipoprotein particle. Here, we investigated the apoptotic effect
of HOCl–LDL, an in vivo occurring LDL modiﬁcation, on human T-cell lymphoblast-like Jurkat cells. Exper-
iments revealed that HOCl–LDL, depending on the oxidant:lipoprotein molar ratio, induces apoptosis via
activation of caspase-3, PARP cleavage and accumulation of reactive oxygen species. The absence of Fas-
associated protein with death domain or caspase-8 in mutant cells did not prevent HOCl–LDL induced
apoptosis. In contrast, overexpression of the anti-apoptotic Bcl-2 protein protects Jurkat cells against
HOCl–LDL-induced apoptosis and prevents accumulation of reactive oxygen species. We conclude that
HOCl–LDL-mediated apoptosis in Jurkat cells follows predominantly the intrinsic, mitochondrial path-
way. In situ experiments revealed that an antibody raised against HOCl–LDL recognized epitopes that
colocalize both with myeloperoxidase and CD3-positive T-cells in human decidual tissue where local
stimulation of the immune system occurs. We provide convincing evidence that formation of HOCl-mod-
iﬁed (lipo)proteins generated by the myeloperoxidase–H2O2–chloride system contributes to apoptosis in
T-cells.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Apoptosis, a type of programmed cell death, is indispensable for
cell growth control and immune defence. The extrinsic apoptotic
pathway requires the binding of a ligand to a death receptor (Fas/
CD95 or TNFR1), which recruits two signal-transducing molecules,
e.g. TNFR1-associated death domain and Fas-associated protein
with death domain (FADD). Binding of procaspase-8 to this complex
results in activation by auto- and transproteolytic cleavage, which
then initiatesproteolytic cleavageof procaspase-3. Caspase-3ﬁnally
executes apoptosis e.g. through cleavage of the nuclear DNA repair
enzyme poly(ADP-ribose)polymerase (PARP), induction of DNA
fragmentation, chromatin condensation, cell shrinking, membrane
blebbing, and formation of apoptotic bodies [1].
The intrinsic apoptotic pathway is due to swelling of mitochon-
dria and release of a variety of apoptotic factors that may either di-
rectly or indirectly induce apoptosis via cytochrome C-mediatedcular Biology and Biochemis-
Fax: +43 316 380 9615.
lle).
Y-NC-ND license.activation of procaspase-9 and subsequent recruitment of procas-
pase-3. Most importantly, the intrinsic apoptotic pathway is under
tight control of members of the Bcl-2 family, which can either pro-
mote cell survival (e.g. Bcl-2 protein) or cell death (Bax) [2].
Apoptosis is a major component of normal development. How-
ever, apoptosis has been also recognized in a number of common
and threatening vascular diseases e.g. atherosclerosis [3], where
excessive accumulation of monocytes/macrophages, smooth mus-
cle cells, and T-lymphocytes, and secretion of cytokines and
growth factors is believed to be a major cause of disease progres-
sion. Most importantly, oxidation of low-density lipoprotein (ox-
LDL) has been implicated in the pathogenesis of various inﬂamma-
tory diseases [4]. For instance, ox-LDL modulates expression of
growth factors, adhesion molecules, and tissue factor, stimulates
smooth muscle cell proliferation, induces monocyte and T-cell
recruitment and activation, and promotes foam cell and fatty
streak formation [4]. Although multiple studies have shown that
copper–ox-LDL, a convenient experimental model for oxidative
LDL modiﬁcation elicits apoptotic cell death in monocytes/macro-
phages (for review see: [5]), knowledge about the consequences of
ox-LDL on lymphocyte apoptosis is limited [6–8]. Activated T-lym-
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that T-cell-mediated immunity contributes to the pathogenesis of
atherosclerosis and other inﬂammatory diseases [3].
The phagocytic enzyme myeloperoxidase (MPO) is abundantly
present in various inﬂammatory diseases. Once activatedMPO gen-
erates hypochlorous acid (HOCl) from H2O2 and physiological chlo-
ride concentrations [10].HOCl, a potent oxidant andbactericidal and
viricidal agent, reacts readily with biomolecules e.g. thiols and thio-
esters, Fe–S centers, nucleotides, unsaturated fatty acids and pro-
teins to form reactive chloramines, which are in turn powerful
oxidants. Most importantly, hypochlorite-modiﬁed LDL (HOCl–
LDL), prone to elicit foamcell formation in vitro [11], is present in hu-
man lesionmaterial [12]. Interactions ofHOCl–LDLwith cells of hae-
matopoietic origin, as well as smooth muscle and endothelial cells
(for review see: [13]) and epithelial cells [14] have been studied
and a panel of atherogenic and proinﬂammatory features have been
reported for this in vivo occurring oxidative LDL modiﬁcation [13].
The present study aimed at investigating the interaction of
HOCl–LDL with T-cells. We were interested whether HOCl–LDL
acts as an initiator of the apoptotic machinery in wild-type lym-
phoblastic Jurkat cells. To reveal whether apoptosis occurs via
extrinsic and/or intrinsic routes, Jurkat cell mutants deﬁcient in
FADD or caspase-8 or overexpressing Bcl-2 were used. MPO-
dependent generation of HOCl-modiﬁed proteins has been de-
tected in various inﬂammatory conditions e.g. atherosclerosis
[15], glomerular and tubulointerstitial injury [16], and placental
tissue [17], where immune cells are contributing. Thus, a speciﬁc
aim of the present study was whether an antibody raised against
HOCl–LDL might detect HOCl-modiﬁed epitopes that colocalize
with T-lymphocytes in human tissues.2. Materials and methods
2.1. Isolation and modiﬁcation of LDL
LDL (d = 1.035 to 1.065 g/ml) was isolated by ultracentrifuga-
tion and desalted as described [18]. Modiﬁcation of LDL (one mg
LDL protein per ml PBS, pH 7.4) was performed with freshly pre-
pared HOCl-solution (4 C overnight, pH 7.4). Treatment with HOCl
(0.4–1.6 mM) resulted in an oxidant:lipoprotein molar ratio in be-
tween 200:1 and 800:1 [19]. HOCl–LDL was passed over a PD10
column preequilibrated with RPMI to remove unreacted HOCl, ﬁl-
tered through a 0.22 lm membrane and used immediately for cell
culture experiments.
2.2. Cells and cell culture experiments
The human T-leukemia Jurkat cell lines (wild-type: JA3 and J16)
were from the American Type Culture Collection (Rockville, MD,
USA). JA3 cells, deﬁcient in FADD (FADDdef) or caspase-8 (Casp-
8def) were provided by Drs. Blenis and Juo. J16 cells overexpressing
Bcl-2 were provided by Dr. Korsmeyer. Cells were cultivated in
RPMI 1640 with 10% FCS, supplemented with 10 mM Hepes,
0.2 M L-glutamine, 25 U/ml penicillin and 25 lg/ml streptomycin
at 37 C in a humidiﬁed 5% CO2 atmosphere [20]. Cells were seeded
into cell culture ﬂasks or 6-well plates and incubated with lipopro-
teins at indicated concentrations for indicated times.
2.3. Apoptosis assays
2.3.1. Detection of DNA strand breaks by the terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL
assay)
Cells (1  106/ml) were incubated with monoclonal antibody
(mAb) CH-11 (200 ng/ml) or lipoproteins. The cells were carefullyresuspended by gently passing through a pipette tip, centrifuged
and resuspended in Hanks balanced solution prior to cytospin
preparation. One hundred ll of the cell suspension were used
per cytospin spot. Cytospins were ﬁxed (15 min, 25 C) with 4%
buffered paraformaldehyde and after rinsing in PBS immersed in
a solution of 0.1% Triton X-100 (v/v) and 0.1% sodium citrate (w/
v) for 2 min at 4 C. After washing with PBS the TUNEL assay was
performed (APOPTOSIS-I.S.-kit from YLEM, Rome, Italy) according
to the manufacturers instructions; however, the streptavidin-per-
oxidase system was replaced by streptavidin-FITC (Dako) (dilution
1:15). Sections were mounted with Moviol (Calbiochem–Novabio-
chem, La Jolla, CA) and analyzed on a confocal laser-scanning
microscope (Leica SP2, Leica Lasertechnik GmbH, Heidelberg, Ger-
many), using the 488 nm laser line for the excitation of FITC (detec-
tion settings were 500–535 nm).
2.3.2. Detection of apoptotic morphological changes by 7-amino-
actinomycin (7-AAD)
For the staining with the DNA speciﬁc dye 7-AAD (Immunotech,
Vienna, Austria) cytospins were ﬁxed with 3% paraformaldehyde
(10 min, 25 C), washed with PBS and incubated with 20 ll of a
7-AAD solution (10 min, 25 C). All incubations were performed
at 25 C in a moist chamber. Sections were mounted as described
above and analyzed by confocal laser-scanning microscopy using
the 488 nm laser line for the excitation of 7-AAD. Detection set-
tings were 535–675 nm.
2.3.3. Determination of DNA fragmentation
As a direct measurement of apoptotic cell death, DNA fragmen-
tation was quantiﬁed as described [20]. Brieﬂy, 2.5  105 cells were
incubated in 24-well plates (Costar, Cambridge, MA) with or with-
out apoptotic stimuli in 0.5 ml of medium at 37 C. Cells were col-
lected by centrifugation at 600g for 10 min at 4 C, washed twice
with PBS, and then resuspended in 100 ll of lysis solution contain-
ing 0.1% (v/v) Triton X-100, 0.1% (w/v) sodium citrate, and 50 lg/
ml propidium iodide. Apoptosis was quantitatively determined
by ﬂow cytometry after incubation at 4 C in the dark for at least
24 h as cells containing nuclei with subdiploid DNA content.
2.3.4. Caspase activity assays
Activity of caspase-3 and -8 was measured ﬂuorimetrically
using the Ac-DEVD-AMC and Ac-IETD-AMC substrates (Sigma). Cell
pellets were lysed (25 mM HEPES, pH 7.5, 5 mM CHAPS, and 5 mM
DTT) on ice (30 min), centrifuged (10.000g, 10 min) and lysates
were incubated with 10 lM Ac-DEVD-AMC in assay buffer
(25 mM HEPES, pH 7.5, 5 mM EDTA, 0.1% CHAPS and 5 mM DTT),
in the presence of 10 mM DTT. Substrate cleavage and accumula-
tion of AMC was followed in 30 min intervals for 2 h in a 96-well
microtiter plate reader (excitation: 360 nm; emission: 460 nm).
Caspase activity was calculated from the rate of AMC released
per min normalized to cell protein content (BCA, Pierce).
2.4. Cell lysis, and Western Blot analysis
Cells (1  106), seeded in 6-well plates under serum-free condi-
tions, were incubated in the absence or presence of lipoproteins. At
indicated times, cells were harvested by centrifugation (5 min,
3500 rpm; 4 C) and washed twice with cold PBS. Cell lysis was
performed on ice in 36 ll lysis buffer (PBS with 1% Triton X-100;
supplemented with protease inhibitor cocktail; Roche Diagnostics,
Mannheim, Germany) for 30 min. Insoluble cell debris was re-
moved by centrifugation (13,000 rpm; 4 C). Protein lysates were
diluted with 4 x reducing sample buffer (8% (w/v) SDS, 18% (v/v)
glycerine, 114 mM Tris; pH 6.8) and boiled for 5 min (95 C). Pro-
teins were separated by PAGE (3.75% or 3.75–15%) under reducing
conditions [19]. After transfer, PVDF membranes were incubated
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anti-caspase-3 (1:1000, Cell Signaling, clone 8G10, #9665), or
mouse anti-PARP (1:3000, Biomol, clone C-2-10) as primary anti-
bodies. Immunoreactive bands were visualized by peroxidase-con-
jugated secondary antibodies (Sigma, Taufkirchen, Germany;
diluted 1:5000) and subsequent ECL-development.
2.5. Analysis of intracellular ROS
Cells were seeded in 24-well plates and incubated with lipopro-
teins (500 lg/ml) for the indicated times and loaded with 10 lM 5-
(and-6)-chloromethyl-20,70-dihydroﬂuorescence diacetate (CM-
H2DCFHDA, Molecular Probes, dissolved in DMSO and pre-diluted
in RPMI 1640) for 30 min at 37 C and 5% CO2 in the dark [21]. Cells
were washed twice with pre-warmed PBS, transferred to a 96-well
microtiter plate and ﬂuorescence was measured at 485 nm (excita-
tion ﬁlters) and 545 nm (emission ﬁlters). Mean ﬂuorescence
intensity was normalized to cell protein content.
2.6. Immunoﬂuorescence
The following primary mAb or polyclonal antibodies were used:
CH-11 (murine mAb, IgM, anti-human Fas, apoptosis inducing,
Coulter Instrumentation Lab.), CD3-phycoerythrin (PE)-labeled
(murine mAb, IgG1, anti-human T-cells, Pharmingen), 2D10G9
(murine mAb, IgG2bk), MNF116 (murine mAb, IgG1, speciﬁc for
cytokeratines present in all trophoblast populations, Dako), PE-la-
beled mouse IgG1 (Pharmingen), polyclonal anti-human MPO anti-
serum (Dako), non-immune mouse IgG (Dako), non immune rabbit
IgG (Sigma). Goat anti-mouse cyanine-2 (Cy-2, Jackson Dianova)
and goat anti-rabbit Cy-5 (Jackson Dianova) were used as second-
ary antibodies.
2.6.1. Tissues
Tissues used for this study were provided from the local Depart-
ment of Obstetrics and Gynecology. Human ﬁrst trimester decidual
tissue was obtained after termination of pregnancy by curettage
for psychosocial reasons (approved by the Ethical Committee of
the Medical School, Karl-Franzens-University Graz). Term placental
tissue was from placentas of normal uncomplicated pregnancies.
Specimens were immediately frozen in a cryostat (Microm, Wall-
dorf, Germany, Microm HM 500 OM), supported by tissue freezing
medium (Tissue Tec OCT-compound, Miles, Elkhard, Ind., USA). Se-
rial cryosections (5 lm) were collected on glass slides, air-dried for
2 h (25 C), ﬁxed in acetone for 5 min (25 C) and stored at -40 C
until required. Decidual tissue was further subjected to immuno-
histochemistry using mAb MNF116 to differentiate between tro-
phoblast-invaded decidua basalis and decidua parietalis.
2.6.2. Immunoﬂuorescence and confocal laser scanning microscopy
For the detection of MPO, HOCl-modiﬁed epitopes, and T-cells,
ﬂuorescence double and triple labeling was performed. Sections
of ﬁrst trimester decidua were thawed, air dried, and ﬁxed in ace-
tone (5 min, 25 C). After re-hydrating in phosphate buffered saline
(PBS, pH 7.4), sections were blocked with UV ultra block (10 min)
and for double labeling incubated (30 min) with mAb 2D10G9
raised against HOCl–LDL [19]. The samples were rinsed in PBS
and incubated (30 min) with Cy-2-labeled goat anti-mouse anti-
body (dilution of 1:300). Then, the sections were incubated with
anti-MPO antiserum, followed by a goat anti-rabbit Cy-5-labeled
mAb (dilution 1:300) [17]. For triple labeling, the sections were
additionally incubated (20 min) with a PE-labeled anti-human
CD3 mAb. All incubation steps were performed in a dark moist
chamber at 25 C.
The samples were analyzed on a confocal laser scanning micro-
scope in sequential mode (Leica SP2), using the 488 nm laser linefor the excitation of Cy-2, the 543 nm line for PE, and the 647 nm
line for Cy-5, respectively. Detection settings were: 500 to
535 nm (Cy-2), 555 nm to 620 nm (PE), and 665 nm to 750 nm
(Cy-5). Negative controls were performed by replacing the primary
antibody by either mouse IgG1, rabbit non-immune IgG or mouse
IgG1 labeled with PE.3. Results and discussion
Oxidative modiﬁcation of LDL generates a panel of highly reac-
tive, toxic compounds that elicit an inﬂammatory response and
may promote apoptosis [5]. Activation of the extrinsic and intrinsic
apoptotic pathways has been studied in cells of mesenchymal ori-
gin e.g. monocytes/macrophages, smooth muscle and endothelial
cells, and T-lymphocytes. While oxidation of LDL by copper leads
to fragmentation of both the protein and the lipid moiety, modiﬁ-
cation of LDL by HOCl, added as reagent or generated enzymati-
cally by the MPO–H2O2–chloride system reacts primarily with
Lys/His and the N-terminal a-amino groups giving rise to forma-
tion of chloramines [13].
Using the TUNEL-assay we show that mAb CH-11 (acting as a
Fas ligand), induced pronounced apoptotic fragmentation in
wild-type Jurkat cells (Fig. 1A). When cells were treated with
HOCl–LDL, fragmentation of nuclear chromatin, a hallmark of
late-stage apoptosis, became apparent. Fig. 1A (upper panel) dem-
onstrates that the degree of chromatin fragmentation dose-depen-
dently increases with an increasing oxidant:lipoprotein molar
ratio. Also staining of DNA with 7-AAD revealed that treatment
of cells with HOCl–LDL (at increasing oxidant:lipoprotein molar ra-
tio) is paralleled by an increasing number of morphologically chan-
ged nuclei with either condensed or already fragmented DNA
(Fig. 1A, lower panel).
Fig. 1B demonstrates no change of procaspase-8 up to 8 h, while
a 24 h treatment with HOCl–LDL led to an impaired immunoreac-
tive procaspase-8 band, indicating a slight involvement of the
extrinsic apoptotic pathway in wild-type cells. Next, activation of
procaspase-3 as well as PARP-cleavage, two processes that are in-
duced by extrinsic/intrinsic pathways, was followed. Western blot
experiments demonstrated that HOCl–LDL led to activation of pro-
caspases-3 (after 8 h) and PARP cleavage in a time-dependent
manner starting 4 h after treatment (Fig. 1B).
In none of the experiments performed, native LDL showed any
signs of apoptosis or nuclear fragmentation in Jurkat cells (Fig. 1).
To get further insights in HOCl–LDL-mediated extrinsic and/or
intrinsic- apoptotic pathway, mutant T-cells were used. HOCl–
LDL treatment increased the number of propidium iodide-positive
Jurkat cells with no signiﬁcant difference between wild-type,
FADDdef or Casp-8def cells (Fig. 2A). However, the number of propi-
dium iodide-positive cells was signiﬁcantly decreased in Bcl-2
cells. Again, native LDL (Fig. 2A) had no signiﬁcant effect on forma-
tion of propidium iodide-positive cells when compared to un-
treated cells (data not shown). Incubation of Jurkat cell lines
with HOCl–LDL (at increasing oxidant:lipoprotein molar ratios) re-
vealed induced PARP cleavage in wild-type, FADDdef and Casp-8def
cells. Although in Bcl-2 cells the 116 kDa full-length PARP tended
to decrease, no evidence of the 86 kDa PARP cleavage product be-
came apparent using HOCl–LDL. This set of experiments suggested
preferential involvement of the intrinsic pathway in wild-type,
FADDdef and Casp-8def cells. Again, native LDL had no impact on
PARP cleavage in all the cell lines investigated (Fig. 2B).
Next, we assessed the activation of both initiator and executor
caspase-8 and caspase-3. Fig. 2C shows that incubation of cells
with HOCl–LDL led to a 2-fold increase of caspase-8 activity (com-
pared to LDL), with no signiﬁcant difference between wild-type
and FADDdef cells. Only background caspase-8 activity was present
Fig. 1. HOCl–LDL induces apoptosis wild-type Jurkat cells: (A) TUNEL assay (upper panel, green signal) and DNA 7-AAD staining (lower panel) of cells in the presence of mAb
CH-11 or 500 lg/ml lipoprotein. The arrows point to morphologically changed nuclei, showing signs of apoptosis. (B) Cells were incubated with 500 lg/ml LDL or HOCl–LDL
(oxidant:lipoprotein molar of 800:1) at indicated times. Cell lysates were subjected to SDS–PAGE andWestern blotting. Membranes were incubated with anti-caspase-8, anti-
caspase-3 or anti-PARP as primary antibodies. One representative experiment out of three is shown: (arrow) procaspase-8 or -3; () 116 kDa full length PARP; () 86 kDa
cleaved PARP. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. HOCl–LDL induces apoptosis in mutant Jurkat cells: (A) Wild-type (WT), FADDdef, Casp-8def and Bcl-2- cells were incubated with 500 lg/ml lipoprotein for 24 h (A) or
8 h (B). Cells were harvested, stained with propidium iodide (PI) and subjected to FACS analysis (A). Cell lysates were subjected to SDS–PAGE, proteins were transferred, and
membranes were incubated with anti-PARP (B). One representative experiment out of three is shown. (C and D) WT, FADDdef and Casp-8def or (E and F) WT and Bcl-2 cells
were treated with 500 lg/ml lipoprotein for 4 h. Activation of caspase-8 (C, E) and caspase-3 (D, F) was measured using Ac-IETD-AMC/Ac-DEVD-AMC as substrates. (C–F)
Caspase activity is given in nmoles AMC/min/lg protein.
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HOCl–LDL activated caspase-3 in wild-type, FADDdef and Casp-
8def cells (Fig. 2D). In contrast, overexpression of mitochondria-
localized Bcl-2 prevented HOCl–LDL-induced activation of cas-
pase-8 and caspase-3 (Fig. 2E and F). Together, these data suggest
that the assembly of a FADD- and caspase-8-containing death-
receptor complex is dispensable for HOCl–LDL-induced apoptosis,
whereas Bcl-2 overexpression prevented HOCl–LDL-mediated
PARP cleavage and activation of caspase-3 and caspase-8, indicat-
ing that the mitochondrial apoptotic cascade is involved.Although ROS play a signiﬁcant role in modulating the intracel-
lular signaling that leads to T-cell proliferation, recent data suggest
that ROS also interfere with signaling events that affect T-cell sur-
vival and activation [22]. ROS appear to regulate apoptosis by
affecting the extrinsic but preferentially the intrinsic pathway. Pre-
vious ﬁndings addressed that highly puriﬁed populations of pri-
mary T-cells produce ROS [22]. We now show that HOCl–LDL
induced formation of ROS in wild-type, FADDdef and Casp-8def cells
(Fig. 3A) and that ROS levels increased with an increasing
oxidant:lipoprotein molar ratio. When compared to wild-type
Fig. 3. HOCl–LDL-mediated ROS formation in Jurkat cells: (A) Wild-type (WT),
FADDdef and Casp-8def cells were incubated with 500 lg/ml HOCl–LDL for 3 h. (B)
WT and Bcl-2 cells were incubated with 500 lg/ml lipoprotein for 3 h. (C) WT cells
were pre-incubated with 25 mM N-acetylcysteine (NAC) for 30 min and treated
with 500 lg/ml lipoprotein for 3 h. ROS levels were calculated by measuring DCF-
ﬂuorescence. Results are expressed as intensity (% of control); data represent
means ± SD (n = 6) ⁄p < 0.05 and ⁄⁄p < 0.01.
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slightly lower in FADDdef cells, indicating that FADD could be in-
volved in ROS production. However, overexpression of Bcl-2 in Jur-
kat cells totally blocked HOCl–LDL-induced ROS accumulation
(Fig. 3B). Preincubation of wild-type Jurkat cells with the antioxi-
dant N-acetylcysteine prior to treatment with HOCl–LDL decreased
ROS formation (Fig. 3C) and apoptosis (data not shown) in further
consequence. In summary, our data show that FADD is slightly in-
volved in HOCl–LDL-induced ROS formation and that overexpres-
sion of Bcl-2 prevents ROS formation. Therefore, we conclude
that HOCl–LDL preferentially activates the intrinsic, mitochondrial
apoptotic pathway.
The capacity of HOCl–LDL to induce the apoptotic machinery
has been investigated in epithelial cells [14], human monocytes
and myelomonocytic cell lines [23–25]. HOCl–LDL has been re-
ported to induce a marked caspase-dependent increase of apopto-Fig. 4. Immunoﬂuorescence for MPO, HOCl-epitopes and T-lymphocytes in human ﬁrst tr
Colocalization of MPO (blue), CD3-positive T-cells (red), and HOCl-modiﬁed epitopes (g
(green) in an area heavily invaded by trophoblast cells. (For interpretation of the referen
article.)sis, loss of mitochondrial membrane potential and activation of
caspase-3, -8, and -9 in U937 cells [24]. While HOCl–LDL was oper-
ative via extrinsic and intrinsic apoptotic pathways in U937 cells
[24,25], the preferential pathway in T-cells involves the intrinsic
route (Figs. 1–3). The fact that overexpression of Bcl-2 in Jurkat
cells or the use of N-acetylcysteine interferes with ROS formation
(Fig. 3B and C) and apoptosis in further consequence (data not
shown) is indicative for mitochondrial involvement. Overexpres-
sion of Bcl-2 in U937 cells even prevented translocation of proa-
poptotic Bax but failed to prevent ROS generation [25]. This
indicates that in U937 cells ROS is an upstream signal to promote
mitochondrial damage [25]. The low activation of caspase-8 (but
pronounced caspase-3 and PARP cleavage) in wild-type cells after
24 h (Fig. 1B) as well as caspase activation and PARP cleavage in
FADDdef or Casp-8def cells and their inhibition by Bcl-2 is of further
support for the intrinsic pathway in T-cells initiated by HOCl–LDL
(Fig. 2). Most importantly, caspase-dependent activation in Jurkat
cells induced by HOCl–LDL could be inhibited by the speciﬁc cas-
pase-3 (7-DEVD.fmk) and caspase-9 inhibitor (Z-LEHD.fmk) (data
not shown) even at lower (lipo)protein concentrations and a lower
oxidant:lipoprotein molar ratio as reported for cells of monocytic
origin [24,25].
Using an antibody raised against HOCl–LDL [19], HOCl-modiﬁed
epitopes were found in inﬂammatory conditions, where T-cells are
involved [15–17]. We here aimed to identify colocalization of
HOCl-modiﬁed proteins with T-cells. Therefore triple labeling
experiments were performed. HOCl-modiﬁed proteins colocalize
with MPO and CD3-positive T-cells in areas of beginning tropho-
blast invasion in ﬁrst trimester decidua basalis (Fig. 4A), demon-
strating involvement of the MPO–H2O2–halide system. Once
heavily invaded, only colocalization of HOCl-modiﬁed proteins
with MPO was detectable in ﬁrst trimester tissue (Fig. 4B). The lack
of CD3-positive T-cells (not shown) is apparently due to a defence
mechanism of the invading trophoblast cells expressing the apop-
tosis inducing Fas-ligand to protect themselves against activated
alloreactive maternal leukocytes [26].
Apoptosis is a physiological process to maintain tissue homeo-
stasis and to complement cell differentiation, migration, and prolif-
eration. Even under pathological conditions, programmed cell
death could represent a ﬁrst line of defence initiated by immune
dysregulation as a local response of T-cells. T-cells are abundantlyimester decidua basalis: (A) staining in an area with beginning trophoblast invasion.
reen). (B) Cell-associated colocalization of MPO (blue) and HOCl-modiﬁed epitopes
ces to colour in this ﬁgure legend, the reader is referred to the web version of this
900 U. Resch et al. / Biochemical and Biophysical Research Communications 410 (2011) 895–900present during early and later stages of inﬂammatory conditions
where modiﬁcation of (lipo)proteins by the MPO–H2O2–chloride
system could amplify this process. We here show that HOCl–LDL,
a physiologically occurring oxidative LDL modiﬁcation, preferen-
tially activates the intrinsic apoptotic pathway. The speciﬁc signal-
ing cascades promoted by HOCl–LDL in wild-type and mutant
Jurkat cell lines are currently under investigation.
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